Realistic simulation of metal nanoparticles on solar cells

[EN] We present a strategy for simulating the scattering effect of an array of self-aggregated (SA) metal nanoparticles (NPs) on the light absorption in solar cells. We include size and shape effects of the NPs, the effect of a layered substrate and the effect of the interaction between NPs. The simulation relies on realistic characterization by SEM microscopy of the random NP arrays. Time and memory limitations of numerical approaches are overcome using semianalytical expressions. Size and shape considerations deal with truncated-sphere shapes by using a polarisability tensor. This is a development of other models leading to equivalent dipoles from the external source and the radiated fields from the rest of NPs. Once an equivalent array of 3-D dipoles is found, the total electromagnetic field and optical simulations are performed. The general trends show good agreement with experimental measurements. A critical analysis of the model is presented, and some improvement strategies are discussed for future studies.The authors would like to thank the R&D fellowship FPI-UPV (P.A.I.D. program of the Universitat Politècnica de València) and the EU-COST project “MultiscaleSolar” (MP1406) and Dr. Stéphane Collin from the Laboratory of Photonics and Nanostructures (CNRS-LPN) for helpful discussions and SEM characterisation.Cortés Juan, F.; Espinosa Soria, A.; Connolly, JP.; Sánchez Plaza, G.; Hugonin, J.; Sanchis Kilders, P. (2015). Realistic simulation of metal nanoparticles on solar cells. Energy Procedia. 84:204-213. doi:10.1016/j.egypro.2015.12.315S2042138

Fecal microbiota composition is related to brown adipose tissue 18F‑fluorodeoxyglucose uptake in young adults

Objective Human brown adipose tissue (BAT) has gained considerable attention as a potential therapeutic target for obesity and its related cardiometabolic diseases; however, whether the gut microbiota might be an efficient stimulus to activate BAT metabolism remains to be ascertained. We aimed to investigate the association of fecal microbiota composition with BAT volume and activity and mean radiodensity in young adults. Methods 82 young adults (58 women, 21.8 ± 2.2 years old) participated in this cross-sectional study. DNA was extracted from fecal samples and 16S rRNA sequencing was performed to analyse the fecal microbiota composition. BAT was determined via a static 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography-computed tomography scan (PET/CT) after a 2 h personalized cooling protocol. 18F-FDG uptake was also quantified in white adipose tissue (WAT) and skeletal muscles. Results The relative abundance of Akkermansia, Lachnospiraceae sp. and Ruminococcus genera was negatively correlated with BAT volume, BAT SUVmean and BAT SUVpeak (all rho ≤ − 0.232, P ≤ 0.027), whereas the relative abundance of Bifidobacterium genus was positively correlated with BAT SUVmean and BAT SUVpeak (all rho ≥ 0.262, P ≤ 0.012). On the other hand, the relative abundance of Sutterellaceae and Bifidobacteriaceae families was positively correlated with 18FFDG uptake by WAT and skeletal muscles (all rho ≥ 0.213, P ≤ 0.042). All the analyses were adjusted for the PET/CT scan date as a proxy of seasonality. Conclusion Our results suggest that fecal microbiota composition is involved in the regulation of BAT and glucose uptake by other tissues in young adults. Further studies are needed to confirm these findings.Universidad de Granada / CBUASpanish Ministry of Economy and Competitiveness via Fondo de Investigacion Sanitaria del Instituto de Salud Carlos III PI13/01393 PTA 12264-IRetos de la Sociedad DEP2016-79512-REuropean Commission Spanish Government FPU13/04365 FPU16/05159 FPU17/01523Fundacion Iberoamericana de Nutricion (FINUT)Redes Tematicas De Investigacion Cooperativa RETIC Red SAMID RD16/0022InFLAMES Flagship Programme of the Academy of Finland 337530NextGenerationEU RR_C_2021_04AstraZenecaUniversity of Granada Plan Propio de Investigacion 2016-Excellence actions: Unit of Excellence on Exercise and Health (UCEES)Junta de Andalucia, Consejeria de Conocimiento, Investigacion y Universidades (ERDF) SOMM17/6107/UGREuropean Commission through the "European funds for regional development" (EFRE)regional Ministry of Economy, Science and Digitalization of Saxony-Anhalt as part of the "Autonomy in old Age"(AiA) research group for "LiLife" Project ZS/2018/11/95324MIRACUMFederal Ministry of Education & Research (BMBF) FKZ 01ZZ1801HFundacion Alfonso Martin Escuder

Traffic Density Exposure, Oxidative Stress Biomarkers and Plasma Metabolomics in a Population-Based Sample: The Hortega Study

Exposure to traffic-related air pollution (TRAP) generates oxidative stress, with downstream effects at the metabolic level. Human studies of traffic density and metabolomic markers, however, are rare. The main objective of this study was to evaluate the cross-sectional association between traffic density in the street of residence with oxidative stress and metabolomic profiles measured in a population-based sample from Spain. We also explored in silico the potential biological implications of the findings. Secondarily, we assessed the contribution of oxidative stress to the association between exposure to traffic density and variation in plasma metabolite levels. Traffic density was defined as the average daily traffic volume over an entire year within a buffer of 50 m around the participants' residence. Plasma metabolomic profiles and urine oxidative stress biomarkers were measured in samples from 1181 Hortega Study participants by nuclear magnetic resonance spectroscopy and high-performance liquid chromatography, respectively. Traffic density was associated with 7 (out of 49) plasma metabolites, including amino acids, fatty acids, products of bacterial and energy metabolism and fluid balance metabolites. Regarding urine oxidative stress biomarkers, traffic associations were positive for GSSG/GSH% and negative for MDA. A total of 12 KEGG pathways were linked to traffic-related metabolites. In a protein network from genes included in over-represented pathways and 63 redox-related candidate genes, we observed relevant proteins from the glutathione cycle. GSSG/GSH% and MDA accounted for 14.6% and 12.2% of changes in isobutyrate and the CH2CH2CO fatty acid moiety, respectively, which is attributable to traffic exposure. At the population level, exposure to traffic density was associated with specific urine oxidative stress and plasma metabolites. Although our results support a role of oxidative stress as a biological intermediary of traffic-related metabolic alterations, with potential implications for the co-bacterial and lipid metabolism, additional mechanistic and prospective studies are needed to confirm our findings.This research was funded by the State Agency for Research (PID2019-108973RB-C21 and C22), by Strategic Action for Research in Health Sciences (PI15/00071 and PI22CIII/00029) from the Spanish Ministry of Economy and Competitiveness and co-funded with European Funds for Regional Development (FEDER), and IDIFEDER/2021/072, CIAICO/2022/181 and INVEST/2023/180 from the Generalitat Valenciana of Spain.S

Impact of Using Different Levels of Threshold-Based Artefact Correction on the Quantification of Heart Rate Variability in Three Independent Human Cohorts

The following are available online at https://www.mdpi.com/2077-0383/9/2/325/s1, Figure S1: Example of a visual inspection of a R-R signal to find possible artefacts or premature contractions across Kubios filters; Figures S2 and S3: Differences on the Heart Rate Variability (HRV) time- and frequency-domains parameters respectively without considering the Very Strong filter; Figure S4: Differences between cohorts on the SDNN using different Kubios filters; Figure S5: Differences between cohorts on the pNN50 using different Kubios filters; and Figure S6: Differences between cohorts on the HF using different Kubios filters.Juan M.A. Alcantara, Abel Plaza-Florido, Jairo H. Migueles, Guillermo Sanchez-Delgado and Francisco J. Amaro-Gahete are supported by the Spanish Ministry of Education, Culture and Sport (FPU15/04059, FPU16/02760, FPU15/02645, FPU13/04365 and FPU14/04172 respectively). Guillermo Sanchez-Delgado is supported by the University of Granada Plan Propio de Investigación 2018 (Programa Contratos-Puente and Programa Perfeccionamiento de Docotres). Francisco J. Amaro-Gahete is supported by the University of Granada Plan Propio de Investigación 2019 (Programa Contratos-Puente). Guillermo Sanchez-Delgado and Borja Martinez-Tellez are supported by individual postdoctoral grants from the Fundación Alfonso Martin Escudero.Heart rate variability (HRV) is a non-invasive indicator of autonomic nervous system function. HRV recordings show artefacts due to technical and/or biological issues. The Kubios software is one of the most used software to process HRV recordings, offering different levels of threshold-based artefact correction (i.e., Kubios filters). The aim of the study was to analyze the impact of different Kubios filters on the quantification of HRV derived parameters from short-term recordings in three independent human cohorts. A total of 312 participants were included: 107 children with overweight/obesity (10.0 ± 1.1 years, 58% men), 132 young adults (22.2 ± 2.2 years, 33% men) and 73 middle-aged adults (53.6 ± 5.2 years, 48% men). HRV was assessed using a heart rate monitor during 10–15 min, and the Kubios software was used for HRV data processing using all the Kubios filters available (i.e., 6). Repeated-measures analysis of variance indicated significant differences in HRV derived parameters in the time-domain (all p < 0.001) across the Kubios filters in all cohorts, moreover similar results were observed in the frequency-domain. When comparing two extreme Kubios filters, these statistical differences could be clinically relevant, e.g. more than 10 ms in the standard deviation of all normal R-R intervals (SDNN). In conclusion, the results of the present study suggest that the application of different Kubios filters had a significant impact on HRV derived parameters obtained from short-term recordings in both time and frequency-domains.The study was funded by the Spanish Ministry of Economy and Competitiveness (DEP2013-47540 and DEP2016-79512-R), the Fondo de Investigación Sanitaria del Instituto de Salud Carlos III (PI13/01393), European Union Development Funds, the Fundación Iberoamericana de Nutrición (FINUT), the Redes Temáticas de Investigación Cooperativa RETIC (Red SAMID RD16/0022), the University of Granada Plan Propio de Investigación 2016 (Excellence actions: Unit of Excellence on Exercise and Health [UCEES]), and the Junta de Andalucía, Consejería de Conocimiento, Investigación y Universidades (FEDER: ref. SOMM17/6107/UGR)

Cost Model Developed in European Project LIMA

[EN] In this paper we show the results of the cost model developed in LIMA project (Seventh Framework Programme, CN: 248909). The LIMA project is entitled "Improve photovoltaic efficiency by applying novel effects at the limits of light to matter interaction". The project started in January 2010 and during this year a cost model of the device developed in the project has been developed to assess the industrial viability of this innovative approach to increase the efficiency and reduce the cost of photovoltaic solar cells. During 2011 the cost model has been actualized and a new scenario has been defined. The LIMA project exploits cutting edge photonic technologies to enhance silicon solar cell efficiencies with new concepts in nanostructured materials. It proposes nanostructured surface layers designed to increase the light absorption in the solar cell while decreasing the surface and interface recombination loss. The integration on a back contact solar cell further reduces these interface losses and avoids shading. The project improves light-matter interaction by the use a surface plasmonic nanoparticle layer. This reduces reflection and efficiently couples incident radiation into the solar cell where it is trapped by internal reflection. Surface and interface recombination are minimized by using silicon quantum dot superlattices in a passivating matrix.This work has been carried out in the framework of the LIMA Project. The European Commission is gratefully acknowledged for financial support under Contract number FP7-248909.Vazquez, M.; Mihailetchi, V.; Connolly, JP.; Cubero García, OJ.; Daly, G.; Halm, A.; Kopecek, R.... (2012). Cost Model Developed in European Project LIMA. Energy Procedia. 27:646-651. https://doi.org/10.1016/j.egypro.2012.07.123S6466512

Strategies for GHG mitigation in Mediterranean cropping systems. A review

In this review we aimed to synthetize and analyze the most promising GHGs mitigation strategies for Mediterranean cropping systems. A description of most relevant measures, based on the best crop choice and management by farmers (i.e., agronomical practices), was firstly carried out. Many of these measures can be also efficient in other climatic regions, but here we provide particular results and discussion of their efficiencies for Mediterranean cropping systems. An integrated assessment of management practices on mitigating each component of the global warming potential (N2O and CH4 emissions and C sequestration) of production systems considering potential side-effects of their implementation allowed us to propose the best strategies to abate GHG emissions, while sustaining crop yields and mitigating other sources of environmental pollution (e.g. nitrate leaching and ammonia volatilization)

Production of upgraded metallurgical-grade silicon for a low-cost, high-efficiency, and reliable PV technology

Upgraded metallurgical-grade silicon (UMG-Si) has the potential to reduce the cost of photovoltaic (PV) technology and improve its environmental profile. In this contribution, we summarize the extensive work made in the research and development of UMG technology for PV, which has led to the demonstration of UMG-Si as a competitive alternative to polysilicon for the production of high-efficiency multicrystalline solar cells and modules. The tailoring of the processing steps along the complete Ferrosolar’s UMG-Si manufacturing value chain is addressed, commencing with the purification stage that results in a moderately compensated material due to the presence of phosphorous and boron. Gallium is added as a dopant at the crystallization stage to obtain a uniform resistivity profile of ∼1 Ω cm along the ingot height. Defect engineering techniques based on phosphorus diffusion gettering are optimized to improve the bulk electronic quality of UMG-Si wafers. Black silicon texturing, compatible with subsequent gettering and surface passivation, is successfully implemented. Industrial-type aluminum back surface field (Al-BSF) and passivated emitter and rear cell (PERC) solar cells are fabricated, achieving cell efficiencies in the range of those obtained with conventional polysilicon substrates. TOPCon solar cell processing key steps are also tested to further evaluate the potential of the material in advanced device architectures beyond the PERC. Degradation mechanisms related to light exposure and operation temperature are shown to be insignificant in UMG PERC solar cells when a regeneration step is implemented, and PV modules with several years of outdoor operation demonstrated similar performance to reference ones based on poly-Si. Life cycle analysis (LCA) is carried out to evaluate the environmental impact of UMG-based PV technology when compared to poly-Si-based technology, considering different scenarios for both the manufacturing sites and the PV installations

HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study

In HIV-1/HCV-coinfected patients, chronic HCV infection leads to an increased T-lymphocyte immune activation compared to HIV-monoinfected patients, thereby likely contributing to increase HIV-1 reservoir that is the major barrier for its eradication. Our objective was to evaluate the influence of HCV coinfection in HIV-1 viral reservoir size in resting (r) CD4+ T-cells (CD25-CD69-HLADR-). Multicenter cross-sectional study of 97 cART-treated HIV-1 patients, including 36 patients with HIV and HCV-chronic co-infection without anti-HCV treatment, 32 HIV patients with HCV spontaneous clearance and 29 HIV-monoinfected patients. rCD4+ T-cells were isolated and total DNA was extracted. HIV viral reservoir was measured by Alu-LTR qPCR. Differences between groups were calculated with a generalized linear model. Overall, 63.9% were men, median age of 41 years and Caucasian. Median CD4+ and CD8+ T-lymphocytes were 725 and 858 cells/mm 3 , respectively. CD4+ T nadir cells was 305 cells/mm 3 . Proviral HIV-1 DNA size was significantly increased in chronic HIV/HCV-coinfected compared to HIV-monoinfected patients (206.21 ± 47.38 vs. 87.34 ± 22.46, respectively; P = 0.009), as well as in spontaneously clarified HCV co-infected patients when compared to HIV-monoinfected individuals (136.20 ± 33.20; P = 0.009). HIV-1/HCV co-infected patients showed a larger HIV-1 reservoir size in comparison to HIV-monoinfected individuals. This increase could lead to a greater complexity in the elimination of HIV-1 reservoir in HIV-1/HCV-coinfected individuals, which should be considered in the current strategies for the elimination of HIV-1 reservoir.Financial support was provided by the Instituto de Salud Carlos III to VB (PI15CIII/00031), by the Spanish Ministry of Economy and Competitiveness to MC (SAF2016–78480-R) and The SPANISH AIDS Research Network RD16CIII/0002/0001, RD16CIII/0002/0002 and RD16/0025/0013 - ISCIII – FEDER. MRLP is supported by ISCIII - Subdirección General de Evaluacion and European Funding for Regional Development (FEDER) (PIE 13/00040 and RD12/0017/0017 RETIC de SIDA). C.P. is supported by the Portuguese Fundação para a Ciência e Tecnologia (FCT) (grant number SFRH/ BPD/77448/2011 is part of the EDCTP2 programme supported by the European Union). V.B., A.F.R. and N.R. are supported by the Miguel Servet programme from Fondo de Investigación Sanitaria (ISCIII) (grant number CP13/00098, CP14/CIII/00010 and CP14/00198, respectively)

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years